Alaa Halawa

Notable investments

• Alloy TherapeuticsSeries E · $40M · 2026
• Salma HealthSeries A · $80M · 2026
• ParadigmSeries B · $78M · 2025
• Ollin BiosciencesSeries A · $100M · 2025
• Tenvie TherapeuticsSeries A · $200M · 2025
• GC TherapeuticsSeries A · $65M · 2024
• Centenara LabsSeries B · $75M · 2023
• EpiBiologicsSeries A · $73M · 2023

Frequently co-invests with

Background

• Board MemberNeumora2021–present
• Board Memberxilis2021–present
• Founding Investor and Board MemberPretzel Therapeutics2021–present
• Board MemberAlloy Therapeutics, Inc.2021–present
• Board ObserverEQRx2021–present
• Board ObserverOutpace Bio2021–present
• InvestorScience 372020–present
• InvestorCiitizen2020–present
• InvestorLyell Immunopharma2020–present
• Board MemberWellpay2020–present
• Board MemberInnovaccer2019–present
• Board ObserverIonQ Inc.2019–present
• InvestorVividion Therapeutics. Inc.2019–present
• Board ObserverUnlearn.AI2019–present
• InvestorPrimer AI2018–present
• InvestorOrca Biosystems Inc.2018–present
• InvestorVir Biotechnology, Inc.2018–present
• Investorinsitro2018–present
• Board ObserverRecursion Pharmaceuticals2017–present
• Head of HealthcareMubadala2017–present
• Board ObserverNewCo
• Executive Director / Head of US VenturesMubadala
• Board MemberXilis
• Board MemberWellPay
• Board ObserverUnlearn.ai
• InvestorInsitro
• InvestorPrimer.ai
• Board ObserverRecursion
• Board ObserverSelf-Employed
• Board ObserverIonQ
• InvestorVividion Therapeutics, Inc.
• InvestorOrca Bio
• Cofounder and Chief Executive OfficerSalma Health
• Founding Investor and Board MemberTenvie Therapeutics
• Founding Investor and Board MemberOllin Biosciences
• Founding InvestorMetsera
• Vice President - Mubadala TechnologyMubadala
• Director, Strategy & Corporate DevelopmentGLOBALFOUNDRIES2014–2015
• Vice President - Mubadala TechnologyMubadala Development Company2009–2014
• Director of Marketing and Product ManagementGlobitel2004–2009

Related lists

Similar investors